Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 76
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Mol Psychiatry ; 14(2): 223-32, 117, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18982005

ABSTRACT

This study reports on the spatiotemporal dynamics of the expression of estrogen receptors (ERs) in the mouse central nervous system (CNS) during the early postnatal and the peripubertal period. At postnatal day 7 (P7), neurons with strong nuclear immunostaining for both ERalpha and ERbeta1 were widely distributed throughout the brain. Sucrose density gradient sedimentation followed by western blotting supported the histochemical evidence for high levels of both ERs at P7. Over the following 2 days, there was a rapid downregulation of ERs. At P9, ERalpha expression was visible only in the hypothalamic area. Decline in ERbeta1 expression was slower than that of ERalpha, and ERalpha-negative, ERbeta1-positive cells were observed in the dentate gyrus and walls of third ventricle. Between P14 and P35, ERs were undetectable except for the hypothalamic area. As before P7, the ovary does not produce estrogen but does produce 5alpha-androstane-3beta, 17beta-diol (3betaAdiol), an estrogenic metabolite of dihydrotestosterone, we examined the effects of high levels of 3betaAdiol in the postnatal period. We used CYP7B1 knockout mice which cannot hydroxylate and inactivate 3betaAdiol. The brains of these mice are abnormally large with reduced apoptosis. In the early postnatal period, there was 1-week delay in the timing of the reduction in ER expression in the brain. These data reveal that the time when ERs might be activated in the brain is limited to the first 8 postnatal days. In addition, the importance of aromatase has to be reconsidered as the alternative estrogen, 3betaAdiol, is important in neuronal function in the postnatal brain.


Subject(s)
Brain/growth & development , Brain/metabolism , Gene Expression Regulation, Developmental/physiology , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Apoptosis , Cytochrome P450 Family 7 , Estradiol/metabolism , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/genetics , Estrogen Receptor beta/metabolism , In Situ Nick-End Labeling/methods , Mice , Mice, Inbred C57BL , Mice, Knockout , Organ Size/genetics , RNA, Messenger/metabolism , Steroid Hydroxylases/deficiency
2.
Science ; 241(4866): 705-8, 1988 Aug 05.
Article in English | MEDLINE | ID: mdl-3041593

ABSTRACT

The human pS2 gene is specifically expressed under estrogen transcriptional control in a subclass of estrogen receptor-containing human breast cancer cells. The pS2 gene encodes an 84-amino acid protein that is secreted after signal peptide cleavage. The distribution of pS2 protein in normal human tissues was studied with antibodies to pS2; pS2 was specifically expressed and secreted by mucosa cells of the normal stomach antrum and body of both female and male individuals. Moreover, no estrogen receptor could be detected in these cells, indicating that pS2 gene expression is estrogen-independent in the stomach. The function of the pS2 protein in the gastrointestinal tract is unknown. However, the pS2 protein is similar in sequence to a porcine pancreatic protein that has been shown to inhibit gastrointestinal motility and gastric secretion.


Subject(s)
Breast Neoplasms/metabolism , Gastric Mucosa/metabolism , Gene Expression Regulation , Neoplasm Proteins/biosynthesis , Proteins , Amino Acid Sequence , Antibodies, Monoclonal , Estrogens/pharmacology , Exons , Female , Histocytochemistry , Humans , Immunoenzyme Techniques , Male , Molecular Sequence Data , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , RNA, Messenger/metabolism , Receptors, Estrogen/metabolism , Sequence Homology, Nucleic Acid , Tissue Distribution , Trefoil Factor-1 , Tumor Cells, Cultured , Tumor Suppressor Proteins
3.
J Clin Invest ; 102(9): 1690-703, 1998 Nov 01.
Article in English | MEDLINE | ID: mdl-9802883

ABSTRACT

We describe a metabolic defect in bile acid synthesis involving a deficiency in 7alpha-hydroxylation due to a mutation in the gene for the microsomal oxysterol 7alpha-hydroxylase enzyme, active in the acidic pathway for bile acid synthesis. The defect, identified in a 10-wk-old boy presenting with severe cholestasis, cirrhosis, and liver synthetic failure, was established by fast atom bombardment ionization-mass spectrometry, which revealed elevated urinary bile acid excretion, a mass spectrum with intense ions at m/z 453 and m/z 510 corresponding to sulfate and glycosulfate conjugates of unsaturated monohydroxy-cholenoic acids, and an absence of primary bile acids. Gas chromatography-mass spectrometric analysis confirmed the major products of hepatic synthesis to be 3beta-hydroxy-5-cholenoic and 3beta-hydroxy-5-cholestenoic acids, which accounted for 96% of the total serum bile acids. Levels of 27-hydroxycholesterol were > 4,500 times normal. The biochemical findings were consistent with a deficiency in 7alpha-hydroxylation, leading to the accumulation of hepatotoxic unsaturated monohydroxy bile acids. Hepatic microsomal oxysterol 7alpha-hydroxylase activity was undetectable in the patient. Gene analysis revealed a cytosine to thymidine transition mutation in exon 5 that converts an arginine codon at position 388 to a stop codon. The truncated protein was inactive when expressed in 293 cells. These findings indicate the quantitative importance of the acidic pathway in early life in humans and define a further inborn error in bile acid synthesis as a metabolic cause of severe cholestatic liver disease.


Subject(s)
Bile Acids and Salts/biosynthesis , Cytochrome P-450 Enzyme System/genetics , Liver Diseases/enzymology , Metabolism, Inborn Errors/enzymology , Mutation , Steroid Hydroxylases/genetics , Amino Acid Sequence , Animals , Base Sequence , Bile Acids and Salts/blood , CHO Cells , Cell Line, Transformed , Cholic Acid/therapeutic use , Cricetinae , Cytochrome P-450 Enzyme System/metabolism , Cytochrome P450 Family 7 , DNA, Complementary , Humans , Infant , Liver/pathology , Liver Diseases/drug therapy , Liver Diseases/genetics , Liver Transplantation , Male , Metabolism, Inborn Errors/drug therapy , Metabolism, Inborn Errors/genetics , Microsomes, Liver/enzymology , Molecular Sequence Data , Steroid Hydroxylases/metabolism , Sterols/blood , Sterols/urine
4.
Oncogene ; 4(11): 1285-90, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2554235

ABSTRACT

The E2 open reading frame of bovine papillomavirus 1 (BPV1) encodes both positive and negative transcriptional regulatory factors. The full-length E2 gene polypeptide is a strong transcriptional transactivator that acts on enhancers within the papillomavirus long control region (LCR), and two shorter E2 proteins function as transcription repressors. A vaccinia recombinant virus harboring the full length E2 coding sequence of BPV1 directs the synthesis of a 48 kD phosphoprotein with specific DNA binding activity. We show that in BPV1-transformed cells the full-length transactivator is a phosphoprotein, whereas truncated E2 proteins were not detectably phosphorylated.


Subject(s)
Bovine papillomavirus 1/genetics , Genes, Viral , Papillomaviridae/genetics , Trans-Activators/genetics , Amino Acids/analysis , Animals , Base Sequence , Bovine papillomavirus 1/metabolism , Cell Line , Cells, Cultured , Cloning, Molecular , DNA, Viral/genetics , DNA, Viral/metabolism , Fluorescent Antibody Technique , Gene Expression , Molecular Sequence Data , Phosphoproteins/analysis , Phosphoproteins/biosynthesis , Restriction Mapping , Trans-Activators/metabolism
5.
J Neurosci ; 21(18): 6993-7000, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11549709

ABSTRACT

Serine proteases in the adult CNS contribute both to activity-dependent structural changes accompanying learning and to the regulation of excitotoxic cell death. Brain serine protease 1 (BSP1)/neuropsin is a trypsin-like serine protease exclusively expressed, within the CNS, in the hippocampus and associated limbic structures. To explore the role of this enzyme, we have used gene targeting to disrupt this gene in mice. Mutant mice were viable and overtly normal; they displayed normal hippocampal long-term synaptic potentiation (LTP) and exhibited no deficits in spatial navigation (water maze). Nevertheless, electrophysiological studies revealed that the hippocampus of mice lacking this specifically expressed protease possessed an increased susceptibility for hyperexcitability (polyspiking) in response to repetitive afferent stimulation. Furthermore, seizure activity on kainic acid administration was markedly increased in mutant mice and was accompanied by heightened immediate early gene (c-fos) expression throughout the brain. In view of the regional selectivity of BSP1/neuropsin brain expression, the observed phenotype may selectively reflect limbic function, further implicating the hippocampus and amygdala in controlling cortical activation. Within the hippocampus, our data suggest that BSP1/neuropsin, unlike other serine proteases, has little effect on physiological synaptic remodeling and instead plays a role in limiting neuronal hyperexcitability induced by epileptogenic insult.


Subject(s)
Genetic Predisposition to Disease , Hippocampus/physiopathology , Kallikreins , Seizures/genetics , Seizures/physiopathology , Serine Endopeptidases/genetics , Action Potentials , Animals , Behavior, Animal , Cell Line , Electric Stimulation , Excitatory Postsynaptic Potentials , Gene Targeting , Hippocampus/drug effects , In Situ Hybridization , In Vitro Techniques , Kainic Acid , Long-Term Potentiation/genetics , Maze Learning , Mice , Mice, Inbred C57BL , Mice, Knockout , Proto-Oncogene Proteins c-fos/biosynthesis , Proto-Oncogene Proteins c-fos/genetics , RNA, Messenger/biosynthesis , Seizures/chemically induced , Serine Endopeptidases/deficiency , Stem Cells
6.
J Mol Biol ; 183(1): 1-12, 1985 May 05.
Article in English | MEDLINE | ID: mdl-4009718

ABSTRACT

Synthetic probes deduced from amino acid sequence data are widely used to detect cognate coding sequences in libraries of cloned DNA segments. The redundancy of the genetic code dictates that a choice must be made between (1) a mixture of probes reflecting all codon combinations, and (2) a single longer "optimal" probe. The second strategy is examined in detail. The frequency of sequences matching a given probe by chance alone can be determined and also the frequency of sequences closely resembling the probe and contributing to the hybridization background. Gene banks cannot be treated as random associations of the four nucleotides, and probe sequences deduced from amino acid sequence data occur more often than predicted by chance alone. Probe lengths must be increased to confer the necessary specificity. Examination of hybrids formed between unique homologous probes and their cognate targets reveals that short stretches of perfect homology occurring by chance make a significant contribution to the hybridization background. Statistical methods for improving homology are examined, taking human coding sequences as an example, and considerations of codon utilization and dinucleotide frequencies yield an overall homology of greater than 82%. Recommendations for probe design and hybridization are presented, and the choice between using multiple probes reflecting all codon possibilities and a unique optimal probe is discussed.


Subject(s)
Amino Acid Sequence , Genetic Code , Oligonucleotides/chemical synthesis , Codon , Humans , Nucleic Acid Hybridization , Statistics as Topic
7.
Mol Endocrinol ; 3(10): 1579-84, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2481815

ABSTRACT

PS2, a small estrogen-inducible secretory polypeptide with structural analogies to a growth factor, is produced by approximately 50% of human breast tumors. The function of PS2 is, however, unknown. To determine whether PS2 may play an autocrine role in the development of mammary tumors we constructed transgenic mice bearing fusion constructs designed to direct the expression of human PS2 in the lactating mammary gland under the control of the whey acidic protein (WAP) promoter. Mouse lines bearing the genomic PS2 gene under the control of the WAP promoter region (WAP-PS2-2) failed to express the transgene. However, mice harboring the fusion construct WAP-PS2-1, in which the PS2 coding sequence is inserted into the 5' untranslated region of the complete WAP gene, were observed to express the transgene. Expression was restricted to the secretory epithelium of the mammary gland during lactation, and PS2 protein was secreted into the milk. Nevertheless, no mammary gland dysplasia was observed, and PS2 expression had no discernable effect upon the physiology and/or development of the suckling young or the transgenic mother.


Subject(s)
Mammary Neoplasms, Experimental/metabolism , Milk/metabolism , Neoplasm Proteins/biosynthesis , Animals , Blotting, Northern , Blotting, Western , Female , Gene Expression Regulation, Neoplastic , Humans , Mammary Neoplasms, Experimental/genetics , Mice , Mice, Transgenic , Neoplasm Proteins/genetics , Nucleic Acid Hybridization , Organ Specificity , RNA/genetics
8.
FEBS Lett ; 589(15): 1819-24, 2015 Jul 08.
Article in English | MEDLINE | ID: mdl-26026270

ABSTRACT

The bacterial cell wall muramyl dipeptides MDP and glucosaminyl-MDP (GMDP) are powerful immunostimulators but their binding target remains controversial. We previously reported expression cloning of GMDP-binding polypeptides and identification of Y-box protein 1 (YB-1) as their sole target. Here we show specific binding of GMDP to recombinant YB-1 protein and subcellular colocalization of YB-1 and GMDP. GMDP binding to YB-1 upregulated gene expression levels of NF-κB2, a mediator of innate immunity. Furthermore, YB-1 knockdown abolished GMDP-induced Nfkb2 expression. GMDP/YB-1 stimulation led to NF-κB2 cleavage, transport of activated NF-κB2 p52 to the nucleus, and upregulation of NF-κB2-dependent chemokine Cxcr4 gene expression. Therefore, our findings identify YB-1 as new target for muramyl peptide signaling.


Subject(s)
Acetylmuramyl-Alanyl-Isoglutamine/analogs & derivatives , Bacteria/metabolism , Cell Wall/metabolism , Immunity, Innate , Y-Box-Binding Protein 1/metabolism , Acetylmuramyl-Alanyl-Isoglutamine/metabolism , Animals , Base Sequence , Binding Sites , Cells, Cultured , DNA Primers , Mice
9.
Endocrinology ; 128(1): 539-46, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1986943

ABSTRACT

A chimeric gene comprising the hydroxymethylglutaryl coenzyme-A reductase promoter and the human GH (hGH) genomic sequences was used to create transgenic mice expressing hGH in all tissues. In transgenic females, morphological development of the mammary gland and milk protein (WAP) expression commences at 3 weeks of age. At 8 weeks of age the mammary gland is morphologically and functionally comparable to that normally reached after 14-15 days of gestation. Precocious development correlated with local expression of hGH in mammary gland. Organ culture in the presence of different lactogenic hormones revealed that insulin and hydrocortisone are sufficient to maintain transcription of the WAP gene in transgenic mammary gland. In contrast, WAP transcription in normal gland required either hGH or PRL in addition to insulin and hydrocortisone. However, the effect of hGH on mammary differentiation does not appear to be solely mediated through an interaction with PRL receptors, since PRL, when added to cultured mammary tissues, did not elicit an equivalent response.


Subject(s)
Growth Hormone/physiology , Mammary Glands, Animal/growth & development , Milk Proteins/biosynthesis , Sexual Maturation , Animals , Female , Growth Hormone/genetics , Humans , Mammary Glands, Animal/cytology , Mammary Glands, Animal/metabolism , Mice , Mice, Transgenic , Organ Culture Techniques , Pregnancy , Reference Values , Restriction Mapping
10.
Genes Brain Behav ; 3(6): 317-27, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15544575

ABSTRACT

Mutant mice simulating human CNS disorders are used as models for therapeutic drug development. Drug evaluation requires a coherent correlation between behavioral phenotype and drug status. Variations in behavioral responses could mask such correlations, a problem highlighted by the three-site studies of Crabbe et al. (1999) and Wahlsten et al. (2003a). Factors contributing to variation are considered, focusing on differences between individual animals. Genetic differences due to minisatellite variation suggest that each mouse is genetically distinct. Effects during gestation, including maternal stress, influence later life behavior; while endocrine exchanges between fetus and parent, and between male and female fetuses dependent on intrauterine position, also contribute. Pre and perinatal nutrition and maternal attention also play a role. In adults, endocrine cyclicity in females is a recognized source of behavioral diversity. Notably, there is increasing recognition that groups of wild and laboratory mice have complex social structures, illustrated through consideration of Crowcroft (1966). Dominance status can markedly modify behavior in test paradigms addressing anxiety, locomotion and aggressiveness, to an extent comparable to mutation or drug status. Understanding how such effects amplify the behavioral spectrum displayed by otherwise identical animals will improve testing.


Subject(s)
Behavior, Animal/physiology , Genetics, Behavioral , Hierarchy, Social , Individuality , Mice, Mutant Strains/physiology , Mice, Mutant Strains/psychology , Prenatal Exposure Delayed Effects , Animals , Disease Models, Animal , Drug Evaluation, Preclinical/methods , Female , Genomic Imprinting , Litter Size , Male , Mice , Nutritional Physiological Phenomena , Pregnancy , Reproducibility of Results , Selection, Genetic , Territoriality
11.
Gene ; 91(2): 179-84, 1990 Jul 16.
Article in English | MEDLINE | ID: mdl-2210379

ABSTRACT

Transgenic mouse lines were established bearing tandem arrays of a fusion construct comprising the promoter region of a housekeeping gene, HMGCR, encoding 3-hydroxy 3-methylglutaryl CoA reductase, linked to a bacterial cat reporter gene encoding chloramphenicol acetyltransferase (CAT). CAT activity was observed in all transgenic mouse tissues examined. The methylation state of the fusion transgene was determined. In non-transgenic mice the endogenous HMGCR promoter is devoid of methylation while flanking regions are extensively modified. In HMGCR-cat transgenic mice the fusion gene promoter was found to be similarly hypomethylated. However, the extent of hypomethylation varied with copy number: methylation-free status was progressively lost with increasing transgene copy number. Further transgenic mouse lines were constructed carrying a truncated HMGCR regulatory region linked to cat. Transgene expression and hypomethylation were observed in testis but not in any other tissue, and testis-specific methylation-free status was also lost at high copy number. Loss of hypomethylation at high copy number may indicate that saturable DNA-binding factors normally protect the HMGCR promoter from methylation.


Subject(s)
DNA, Recombinant , Hydroxymethylglutaryl CoA Reductases/genetics , Promoter Regions, Genetic , Animals , Blotting, Southern , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Cloning, Molecular , Genes , Methylation , Mice , Mice, Transgenic , Restriction Mapping
12.
Gene ; 159(2): 181-6, 1995 Jul 04.
Article in English | MEDLINE | ID: mdl-7622046

ABSTRACT

The normal function of the pathogenicity-related protein, PrP (or prion protein), is unknown. To shed light on functionally important domains, we have characterized a candidate marsupial PrP gene. The deduced marsupial PrP has an overall identity of about 80% to eutherian PrP at the amino acid (aa) level. This similarity is not equally distributed and two regions (aa 118-142 and 177-223) are particularly highly conserved. In contrast, a repeat region in the N-terminal half of the marsupial PrP shows dipeptide inserts not described in other PrP. Another particular feature of the marsupial gene is the lack of a continuous ORF on the antisense strand, as is found in most eutherian PrP. We propose that antisense ORFs found in other species are artefactual. Comparison with all known PrP argues that the molecule characterised is the true marsupial PrP orthologue.


Subject(s)
Marsupialia/genetics , Prions/genetics , Amino Acid Sequence , Animals , Base Sequence , Conserved Sequence , DNA, Antisense/genetics , Mammals/genetics , Molecular Sequence Data , Open Reading Frames/genetics , Restriction Mapping , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Species Specificity
13.
Gene ; 57(2-3): 193-201, 1987.
Article in English | MEDLINE | ID: mdl-2826295

ABSTRACT

Plasmid (pPolyIII) and bacteriophage lambda (EMBL301) vectors are described in which sites for the rare-cutting enzymes SfiI and NotI (8-bp, recognition sequences) flank the polylinker cloning region. Intact DNA inserts for introduction into cultured cells or into the early embryo are readily excised from the vectors. General-purpose miniplasmid cloning vectors pPolyI and pPolyII are also described, and the utility of the bacteriophage lambda vector is demonstrated in the construction of a bovine genomic library.


Subject(s)
Bacteriophage lambda/genetics , DNA Transposable Elements , Genetic Vectors , Plasmids , Animals , Base Sequence , Cattle , Chromosome Mapping , Cloning, Molecular , Molecular Sequence Data , Oligodeoxyribonucleotides/genetics
14.
Gene ; 26(1): 91-9, 1983 Dec.
Article in English | MEDLINE | ID: mdl-6323254

ABSTRACT

A new pair of cloning and sequencing vectors based on bacteriophage M13mp7 has been developed. These vectors (M13tg130 and M13tg131) contain, in addition to the EcoRI, BamHI, HindIII, SmaI, SalI and PstI sites present in other vectors [cf., M13mp8 and M13mp9, Messing and Vieira, Gene 19 (1982) 269-276], unique restriction recognition sequences for the enzymes EcoRV, KpnI, SphI, SstI and XbaI. A restriction site for the enzyme BglII has been incorporated into the polylinker region of one of the vector pair to permit rapid discrimination between the two vectors.


Subject(s)
Cloning, Molecular , Coliphages/genetics , Genetic Vectors , DNA Restriction Enzymes , DNA Transposable Elements , DNA, Viral/genetics , Escherichia coli/genetics
15.
Gene ; 20(2): 187-95, 1982 Dec.
Article in English | MEDLINE | ID: mdl-6299886

ABSTRACT

A method is proposed for linking a DNA fragment possessing a 5' single-stranded extension to one carrying a 3' extension. Synthetic oligonucleotide adaptors can be used to (i) change the site specificity at the termini of a fragment generated by restriction enzyme cleavage and (ii) simultaneously dephosphorylate the extremities of a DNA molecule to prevent recircularisation and allow positive selection for recombinant DNA molecules.


Subject(s)
DNA Restriction Enzymes/metabolism , DNA, Recombinant/metabolism , Oligodeoxyribonucleotides/genetics , Oligonucleotides/genetics , Plasmids , Amino Acid Sequence , Base Sequence , DNA Ligases , T-Phages/enzymology
16.
Gene ; 73(1): 163-73, 1988 Dec 15.
Article in English | MEDLINE | ID: mdl-2977356

ABSTRACT

We previously reported that live recombinant vaccinia viruses (VV) encoding either the large T (LT) or middle T (MT) antigens of polyoma virus (PyV) were able to induce rejection of tumors caused by PyV-transformed cells [Lathe et al., Nature 326 (1987) 878-880]. Here we present evidence that PyV early proteins expressed by the recombinants retain the biochemical characteristics of their authentic counterparts despite the cytopathic effect of VV infection. VV-encoded LT is a nuclear phosphoprotein, with specific DNA binding, ATPase and nucleotide-binding activities. VV-expressed MT associates with cellular kinases, particularly with pp60c-src, by which it is phosphorylated in vitro. Expression levels of LT and MT reached 10(6) molecules per infected cell. The use of VV as a vector is encouraged by the high expression level obtained and because VV infection does not seem to prevent appropriate post-translational processing of proteins encoded by VV recombinants.


Subject(s)
Antigens, Polyomavirus Transforming/genetics , Vaccinia virus/genetics , Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/metabolism , Animals , Blotting, Western , Cell Line , Cell Transformation, Viral , Fluorescent Antibody Technique , Humans , Phosphorylation , Protein Kinases/genetics , Protein Kinases/metabolism , Recombination, Genetic
17.
Gene ; 93(2): 313-8, 1990 Sep 14.
Article in English | MEDLINE | ID: mdl-1688329

ABSTRACT

A human gene and cDNA coding for a breast-cancer-associated antigen (H23Ag) were isolated and characterized. The gene contains two exons and one intron. Part of the second exon is a tandem repeat array (TRA) consisting of multiple 60-bp G + C-rich units. We report here the characterization of unique sequences that are found in the H23Ag gene and cDNA, in addition to the 60-bp repeats. Analysis of the cDNA sequences revealed a putative ATG start codon preceded by two overlapping initiation consensus sequences (CCACC). The open reading frame determines an amino acid (aa) sequence consisting of three regions. The first region contains an initiating methionine and a highly hydrophobic putative signal peptide. This is followed by a variable number of highly conserved 20-aa repeat units (TRA). The last region, C-terminal to TRA, contains four potential N-linked glycosylation sites. The genomic nucleotide sequences demonstrate a putative promoter region that includes a 'TATA' box. A putative estrogen regulatory element is located 5' to the promoter region. The characterization of the gene and cDNA coding for the H23Ag presented here, may help to elucidate its possible function in human breast cancer.


Subject(s)
Antigens, Neoplasm/genetics , Breast Neoplasms/genetics , Genetic Variation , Membrane Glycoproteins/genetics , Mucins/genetics , Neoplasm Proteins/genetics , Amino Acid Sequence , Base Sequence , Breast Neoplasms/immunology , Consensus Sequence , DNA/chemistry , Humans , Introns , Molecular Sequence Data , Mucin-1 , Repetitive Sequences, Nucleic Acid , Restriction Mapping , Sequence Homology, Nucleic Acid , TATA Box
18.
Eur J Cancer ; 27(6): 770-3, 1991.
Article in English | MEDLINE | ID: mdl-1829922

ABSTRACT

Expression of the pancreatic spasmolytic peptide (hSP) gene and pS2 (a gene isolated from oestrogen-induced breast carcinoma cells) were analysed in 36 samples of human stomach carcinoma. 17 tumours were investigated at the RNA level (by northern blots) as well as at the gene product level (by immunochemistry). Since pS2 had been shown to be expressed in normal stomach mucosa its activity in carcinoma samples was expected. Surprisingly, strong pS2 immunoreactivity was noted in the diffuse carcinoma type, whereas the intestinal type displayed weak reactivity. The tumour samples showing strong immunostaining expressed the regular 0.6 kb pS2 RNA band and weak staining was paralleled by aberrant transcripts. Additionally, only in tumour samples with regular pS2 transcription was the typical 0.7 kb hSP RNA band seen; samples with aberrant pS2 bands did not express hSP at all. This is the first demonstration of hSP gene activity in a human tumour.


Subject(s)
Breast Neoplasms/genetics , Mucins , Muscle Proteins , Neuropeptides , Parasympatholytics/metabolism , Peptides/genetics , Stomach Neoplasms/genetics , Blotting, Northern , Blotting, Southern , Gene Expression , Humans , Intercellular Signaling Peptides and Proteins , RNA, Neoplasm/analysis , Trefoil Factor-2 , Trefoil Factor-3
19.
Biochimie ; 70(8): 1075-87, 1988 Aug.
Article in English | MEDLINE | ID: mdl-2852508

ABSTRACT

Live vaccinia virus recombinants expressing viral antigens have recently been developed as effective anti-viral vaccines. We have examined the possibility of extending this approach to specific anti-tumor immunity, using tumors induced by the polyoma virus (PyV) as a model system. Three recombinant vaccinia viruses, separately encoding the three early proteins of the polyoma virus (large, middle and small tumor (T) antigens) were constructed. Each recombinant efficiently expresses the appropriate T antigen, which exhibits biochemical properties and subcellular localization of the authentic PyV protein. The potential of the recombinants to elicit immunity towards PyV-induced tumors was assessed in rats by a challenge injection of syngeneic PyV-transformed cells. After prior immunization with the large-T or the middle-T viruses, small tumors developed, which later regressed and were eliminated in more than 50% of the animals. In contrast, the small-T virus failed to elicit tumor rejection. Established tumors could also be eliminated by curative vaccinations. No circulating antibodies directed against PyV large-T or middle-T antigens were detected in animals vaccinated with the large-T or middle-T viruses, suggesting that rejection may be due to a cell-mediated immune response.


Subject(s)
Antigens, Viral, Tumor/administration & dosage , Polyomavirus/immunology , Recombinant Proteins/administration & dosage , Vaccinia virus/immunology , Viral Vaccines/administration & dosage , Animals , Antigens, Viral, Tumor/genetics , Genetic Vectors , Immunotherapy , Neoplasms, Experimental/therapy , Plasmids , Rats
20.
J Mol Endocrinol ; 6(2): 129-35, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2043241

ABSTRACT

Glucose tolerance was studied in transgenic mice (SJL x C57BL/6) expressing human GH under the control of a housekeeping promoter. Parental SJL mice were found to harbour a dominant allele, termed here glid, determining glucose intolerance in pure-bred animals and in F1 hybrids with glucose-tolerant C57BL/6 mice. Blood glucose levels in transgenic SJL x C57BL/6 hybrid mice were well controlled following glucose challenge, whereas non-transgenic hybrids failed to control their glucose adequately. Pancreatic morphology was normal in all animals. In confirmation of a physiological role for GH in glucose regulation. GH-deficient lit/lit mice were pathologically sensitive to glucose.


Subject(s)
Blood Glucose/metabolism , Glucose Tolerance Test , Growth Hormone/genetics , Hyperglycemia/genetics , Insulin/metabolism , Alleles , Animals , Genes, Dominant , Growth Hormone/physiology , Homeostasis , Humans , Insulin/blood , Insulin Secretion , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Mice, Transgenic , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL